Literature DB >> 18598940

The HECT family of E3 ubiquitin ligases: multiple players in cancer development.

Francesca Bernassola1, Michael Karin, Aaron Ciechanover, Gerry Melino.   

Abstract

The involvement of the homologous to E6-AP carboxyl terminus (HECT)-type E3s in crucial signaling pathways implicated in tumorigenesis is presently an area of intense research and extensive scientific interest. This review highlights recent discoveries on the ubiquitin-mediated degradation of crucial tumor suppressor molecules catalyzed by the HECT-type E3s. By providing a portrait of their protein targets, we intend to link the substrate specificity of HECT-type E3s with their contribution to tumorigenesis. Moreover, we discuss the relevance of targeting the HECT E3s, through the development of small-molecule inhibitors, as an anticancer therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598940     DOI: 10.1016/j.ccr.2008.06.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  263 in total

1.  Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs.

Authors:  Gozde Kar; Ozlem Keskin; Ruth Nussinov; Attila Gursoy
Journal:  J Proteome Res       Date:  2012-01-10       Impact factor: 4.466

Review 2.  Twists and turns in ubiquitin-like protein conjugation cascades.

Authors:  Brenda A Schulman
Journal:  Protein Sci       Date:  2011-11-09       Impact factor: 6.725

3.  Bul proteins, a nonredundant, antagonistic family of ubiquitin ligase regulatory proteins.

Authors:  Tatiana V Novoselova; Kiran Zahira; Ruth-Sarah Rose; James A Sullivan
Journal:  Eukaryot Cell       Date:  2012-02-03

4.  The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.

Authors:  Kristina Subik; Lei Shu; Chengyu Wu; Qianqian Liang; David Hicks; Brendan Boyce; Linda Schiffhauer; Di Chen; Ceshi Chen; Ping Tang; Lianping Xing
Journal:  Bone       Date:  2012-01-11       Impact factor: 4.398

5.  Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination.

Authors:  Zhizhi Wang; Gregory A Michaud; Zhihong Cheng; Yue Zhang; Thomas R Hinds; Erkang Fan; Feng Cong; Wenqing Xu
Journal:  Genes Dev       Date:  2012-01-19       Impact factor: 11.361

Review 6.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

7.  Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2.

Authors:  Thomas Mund; Hugh R B Pelham
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

8.  Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

Authors:  Mohammad Abu-Odeh; Tomer Bar-Mag; Haiming Huang; TaeHyung Kim; Zaidoun Salah; Suhaib K Abdeen; Marius Sudol; Dana Reichmann; Sachdev Sidhu; Philip M Kim; Rami I Aqeilan
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

Review 9.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

10.  miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.

Authors:  G Yang; Y Gong; Q Wang; L Wang; X Zhang
Journal:  Oncogene       Date:  2016-08-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.